Friday 6 November 2026 Export IMNM’s income statement to Excel — free account

Immunome, Inc.

IMNM Healthcare Biotechnology

Immunome, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.9 million, down 23.2% from fiscal 2024.

Revenue: +69.8%
EPS: −30.0%
Free cash flow: −27.0%

Quarter to June 2026, against a year earlier

Insider buying

18.78 0.87 +4.86%

Follow IMNM

Alert me

Market cap: $2.1B
P/E: 0.0×
Fwd P/E: −7.6×
Dividend yield: —
F-score: 4/9
Altman Z: 21.57
Beneish M: n/a
Dividend safety: n/a

Overview

Immunome, Inc. (IMNM) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Immunome, Inc. (IMNM) trades at a P/S ratio of 162×. Over the past ten years it has ranged from 0.0× (December 2023) to 268× (August 2026); the current reading is higher than 90% of that period. That is above the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/IMNM/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Immunome, Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/IMNM/metrics/ps-ratio">Immunome, Inc. (IMNM) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	149×	116.38%
FY2024	68.9×	341.94%
FY2023	15.6×	—

Period	P/S ratio	Change
Jun 2025	64.3×	31.56%
Mar 2025	48.9×	(29.07%)
Dec 2024	68.9×	(20.74%)
Sep 2024	86.9×	28.16%
6 more quarters	Free account

Against its own ten years

Low 0.0× High 268×

Ten-year median 0.0×

Current reading's percentile 90

Company	P/S ratio
VERA Vera Therapeutics, Inc. compare	n/m
BHVN Biohaven Ltd. compare	2.1×
ADMA ADMA Biologics Inc compare	5.7×
AUPH Aurinia Pharmaceuticals Inc compare	6.7×
LKFT Lakefront Biotherapeutics - Sponsored ADR compare	7.9×
VCEL Vericel Corporation compare	8.1×
PVLA Palvella Therapeutics, Inc. compare	54.1×
IMNM Immunome, Inc.	162×
CLDX Celldex Therapeutics, Inc. compare	2,498×
Biotechnology industry median	9.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Immunome, Inc. (IMNM) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on IMNM

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on IMNM

Stockrow Weekly